SCHEMBL31695348

SCHEMBL31695348

N#Cc1c(-c2ccc(O)c(O)c2)cc(-c2ccc(O)cc2)[nH]c1=N

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 8/20 0.47
▸ BIRC5 O15392 3/20 0.42
▸ IL4 P05112 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ ADORA1 P30542 3/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ BCL2L1 Q07817 1/20 0.37
▸ APP P05067 1/20 0.37
▸ MET P08581 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31695346 0.91 ATM (0.51) PIM1BIRC5ALOX5ATMMEN1
SCHEMBL31695313 0.90 IL4 (0.54) PIM1BIRC5IL4ATMMEN1
SCHEMBL31695357 0.90 IL4 (0.45) PIM1BIRC5IL4ATMADORA1
SCHEMBL31695323 0.90 MAPT (0.50) PIM1BIRC5IL4ATMMEN1
SCHEMBL31695345 0.90 ATM (0.50) PIM1BIRC5ALOX5ATMMEN1
SCHEMBL29335418 0.90 IL4 (0.54) PIM1BIRC5IL4ATMMEN1
SCHEMBL31695347 0.84 ALOX5 (0.49) PIM1BIRC5IL4ALOX5ATM
SCHEMBL31695290 0.82 MET (0.48) PIM1BIRC5IL4ADORA2AALDH1A1
SCHEMBL31695334 0.79 IL4 (0.43) PIM1BIRC5IL4ATMADORA1
SCHEMBL31695360 0.79 IL4 (0.43) PIM1BIRC5IL4ATMADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 PIM1 585/4885BIRC5 636/4885IL4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback